We observed a reduced phosphorylation of p42/44 (Erk1/2) and the ribosomal protein S6 after treatment with MEKi and HSP90i (Figure S3A), showing that this drug combination is effective in CRC organoids. The gene discussed is MAPK3; the disease is colorectal carcinoma.